hKHK
Nomenclature
C57BL/6JSmo-Khktm1(hKHK)Smoc
Cat. NO.
NM-HU-233514
Strain State
Repository Live
Gene Summary
Gene Symbol
Khk
Model Description
Validation Data

Fig.1 Detection of KHK expression in liver, kidney and small intestine by RT-PCR. Mouse Khk mRNA (165 bp) was detectable only in wild-type C57BL/6 mice. Human KHK mRNA (183 bp) was detectable only in homozygous hKHK knockin mice but not in wild-type mice. Liver, kidney and small intestine RNA was extracted from 6-week-old female wild-type C57BL/6 (WT)(n=3) and homozygous hKHK knockin mice (HO) (n=3), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers.
Abbr. M, marker; HO, homozygous; WT, wild type.

Fig.2 Detection of KHK expression in liver, kidney and small intestine by qPCR. Mouse Khk mRNA was detectable only in wild-type C57BL/6 mice. Human KHK mRNA was detectable only in homozygous hKHK knockin mice but not in wild-type mice. Liver, kidney and small intestine RNA were extracted from 6-week-old female wild-type C57BL/6 (WT)(n=3) and homozygous hKHK knockin mice (HO) (n=3), then cDNA libraries were synthesized by reverse transcription, followed by qPCR with human KHK, mouse Khk and mouse Gapdh primers. Relative expression represents the human KHK mRNA level relative to its average expression in homozygous hKHK knockin mice. Relative expression represents the mouse Khk mRNA level relative to its average expression in wild-type mice.
Abbr. M, marker; HO, homozygous; WT, wild type.

Fig.3 Detection of KHK expression in hKHK mice by WB. KHK was detectable in liver and kidney from both WT C57BL/6 and HO hKHK mice , as the antibody was cross-reactived between human and mouse KHK. The liver and kidney tissue lysates were collected from 7-week-old male wild-type C57BL/6 mice and 7-week-old male homozygous hKHK mice, and then analyzed by western blot with anti-KHK antibody.
Abbr. HO, homozygous; WT, wild type; PC, positive control, HepG2 cells.
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more